Galera Therapeutics, Inc. · OTC:GRTX

Sorensen Mel disposed of 975 Galera Therapeutics, Inc. shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 5, 2026

On Aug 3, 2026, Sorensen Mel (Director, President and CEO) disposed of 975 Galera Therapeutics, Inc. shares, leaving 0 shares. Filed Aug 5, 2026 (Form 4).

Disposed of
975 shares
Holding after
0 shares
Trading plan
No
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 3, 2026Common StockDisposition9750Direct

Source

View original at SEC

Related